Wilson Wendy
Known title: DirectorCIK: 0001862057
Associated companies
Transaction History
| DVLT | ▼ Sell | Open Market | 25,856 | $10K | 6/11/2026 | View on chart |
| DVLT | ▲ Buy | Grant | 250,000 | $0 | 4/20/2026 | View on chart |
| DVLT | ▲ Buy | Grant | 211,203 | $0 | 11/25/2025 | View on chart |
| DVLT | ▲ Buy | Grant | 26,372 | $0 | 6/25/2025 | View on chart |
| DVLT | ▲ Buy | Grant | 74,334 | $0 | 2/26/2025 | View on chart |
| DVLT | ▲ Buy | Grant | 7,424 | $0 | 11/12/2024 | View on chart |
| DVLT | ▲ Buy | Grant | 7,543 | $0 | 7/30/2024 | View on chart |
| DVLT | ▲ Buy | Grant | 4,616 | $0 | 6/7/2024 | View on chart |
| DVLT | ▲ Buy | Grant | 11,000 | $0 | 7/12/2023 | View on chart |
| DVLT | ▲ Buy | Grant | 12,000 | $0 | 1/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
DataMeds AI files DBAs for new health entities
DataMeds AI, the parent company of Datavault AI, has filed DBAs for 'DataMeds SI' and 'Corexa Health SI.' These filings suggest the company is expanding its operations into specific health-related segments. The move provides context for the stock's current trading levels relative to its 52-week range.
DataMeds AI files DBAs for new health entities. DataMeds AI, the parent company of Datavault AI, has filed DBAs for 'DataMeds SI' and 'Corexa Health SI.' These filings suggest the company is expanding its operations into specific health-related segments. The move provides context for the stock's current trading levels relative to its 52-week range.